Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Loncar Cancer Immunotherapy ETF (CNCR)

26.55 -0.26 (-0.97%)

04-20 16:00

Open:

26.75

Pre. Close:

26.81

High:

26.78

Low:

26.4775

Volume:

19,107

Market Cap:

1214M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

26.809 - 27.028

27.028 - 27.174

Low:

26.021 - 26.265

26.265 - 26.429

Close:

26.232 - 26.608

26.608 - 26.861

Technical analysis  (as of: 2018-04-20 4:28:27 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 34.13     One year: 36.18

Support:

Support1: 26.38    Support2: 21.95

Resistance:

Resistance1: 29.22    Resistance2: 30.98

Pivot:

27.63

Moving Averages:

MA(5): 27.12     MA(20): 28.04

MA(100): 27.28     MA(250): 25.39

MACD:

MACD(12,26): -0.62     Signal(12,26,9): -0.49

%K %D:

%K(14,3): 16.67     %D(3): 22.83

RSI:

RSI(14): 36.85

52-Week:

High: 32.32  Low: 21.09  Change(%): 15.1

Average Vol(K):

3-Month: 4431  10-Days 4835

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
CNCR has closed above bottom band by 8.3%. Bollinger Bands are 11% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-04T07:59:46-04:00
Healthcare sector in the red premarket on Trump/Xi tariff tit-for-tat

2018-03-15T15:59:47-04:00
Billions on the line as White House and insurers wait for appeals court decision on ACA payments

2018-02-26T18:09:53-05:00
This 'Feel Good' ETF Is A Top ETF Performer This Year

2018-02-16T08:00:00-05:00
Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million in Assets Under Management

2018-02-05T06:57:34-05:00
Will healthcare stocks hold steady amidst broad selloff?

2018-01-16T11:07:19-05:00
FDA launches accelerated review program for products needed by DoD

2018-01-12T20:58:44-05:00
Separating Winners From Losers In A Volatile Healthcare Environment

2018-01-08T11:56:31-05:00
Start of JPM18 fails to buoy healthcare stocks

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

2.10

Shares Float (M)

2.10

% Held by Insiders

% Held by Institutions

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

4.420

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-27.8

Return on Equity (ttm)

-31.3

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

6.01

P/S

P/CF

Dividend Yield

0.04

Dividends & Splits

Dividend

1.143

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.